Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FOUAD CHEBIB

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1235450602
CMS profile
398342
Location
JACKSONVILLE, FL

General Payments · PY2018–2024

$84,647.90

  • Reported across 66 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$43,707.71

29 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,394.37 10
PY2019 $2,835.19 8
PY2020 $4,993.53 2
PY2021 $6,390.00 4
PY2022 $7,948.58 5
PY2023 $14,378.52 8
PY2024 $43,707.71 29

Payment records · PY2024 (29)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
CALLIDITAS THERAPEUTICS US INC. $56.60 12/07/2024 Food and Beverage Undisputed 01/23/2026 1141528869 CMS
CALLIDITAS THERAPEUTICS US INC. $91.29 12/08/2024 Food and Beverage Undisputed 01/23/2026 1141528965 CMS
Hikma Pharmaceuticals USA $1,200.00 10/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1127502855 CMS
Otsuka America Pharmaceutical, Inc. $412.92 08/25/2024 Travel and Lodging Undisputed 01/23/2026 1118874046 CMS
Otsuka America Pharmaceutical, Inc. $38.99 08/26/2024 Travel and Lodging Undisputed 01/23/2026 1118874048 CMS
Otsuka America Pharmaceutical, Inc. $43.78 08/26/2024 Food and Beverage Undisputed 01/23/2026 1118874050 CMS
Otsuka America Pharmaceutical, Inc. $52.60 08/26/2024 Food and Beverage Undisputed 01/23/2026 1118874052 CMS
Otsuka America Pharmaceutical, Inc. $38.99 08/26/2024 Travel and Lodging Undisputed 01/23/2026 1118874054 CMS
Otsuka America Pharmaceutical, Inc. $607.94 08/27/2024 Travel and Lodging Undisputed 01/23/2026 1118874056 CMS
Otsuka Pharmaceutical Co., Ltd. $4,015.00 06/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1093180326 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $18,615.00 10/03/2024 Consulting Fee Undisputed 01/23/2026 1118835961 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $51.84 10/08/2024 Food and Beverage Undisputed 01/23/2026 1118835963 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $98.61 10/08/2024 Travel and Lodging Undisputed 01/23/2026 1118835965 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $33.45 10/08/2024 Travel and Lodging Undisputed 01/23/2026 1118835967 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $85.63 10/08/2024 Travel and Lodging Undisputed 01/23/2026 1118835969 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $118.58 10/08/2024 Travel and Lodging Undisputed 01/23/2026 1118835971 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $99.54 10/08/2024 Travel and Lodging Undisputed 01/23/2026 1118835973 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $107.08 10/08/2024 Travel and Lodging Undisputed 01/23/2026 1118835975 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $73.16 10/08/2024 Food and Beverage Undisputed 01/23/2026 1118835977 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $125.00 10/17/2024 Food and Beverage Undisputed 01/23/2026 1118835979 CMS
VERTEX PHARMACEUTICALS INCORPORATED $651.75 07/25/2024 Travel and Lodging Undisputed 01/23/2026 1105918554 CMS
VERTEX PHARMACEUTICALS INCORPORATED $33.89 07/26/2024 Food and Beverage Undisputed 01/23/2026 1105907455 CMS
VERTEX PHARMACEUTICALS INCORPORATED $766.26 07/26/2024 Travel and Lodging Undisputed 01/23/2026 1105908882 CMS
VERTEX PHARMACEUTICALS INCORPORATED $9.46 07/26/2024 Food and Beverage Undisputed 01/23/2026 1105909548 CMS
VERTEX PHARMACEUTICALS INCORPORATED $14.61 07/26/2024 Food and Beverage Undisputed 01/23/2026 1105911676 CMS
VERTEX PHARMACEUTICALS INCORPORATED $54.69 07/26/2024 Travel and Lodging Undisputed 01/23/2026 1105913070 CMS
VERTEX PHARMACEUTICALS INCORPORATED $27.55 07/26/2024 Food and Beverage Undisputed 01/23/2026 1105915808 CMS
VERTEX PHARMACEUTICALS INCORPORATED $508.50 09/11/2024 Travel and Lodging Undisputed 01/23/2026 1105908884 CMS
VERTEX PHARMACEUTICALS INCORPORATED $15,675.00 09/25/2024 Consulting Fee Undisputed 01/23/2026 1105923361 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.